Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Ede-Golightly Insider Profile
4 Followers
James Ede-Golightly, Director at Silence Therapeutics, holds 3.00K shares in Silence Therapeutics (Ticker: GB:SLN), holds 645.11K shares in Plant Health Care (Ticker: GB:PHC). Most recently, James Ede-Golightly Bought ― shares of Silence Therapeutics on Oct 12, 2020 for an estimated value of 12.26K.
James Ede-Golightly Silence Therapeutics (SLN)Director
Silence Therapeutics (SLN)
Director
Ranked #19,765 out of 97,944 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+34.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of James Ede-Golightly's holdings
Insider Roles
Director
Roles that James Ede-Golightly holds in companies
Most Profitable Insider Trade
Stock:
Silence Therapeutics
(SLN)
(SLN)
Rating:Informative Buy
Date:Oct 12, 2020 - Oct 12, 2021
Return:+43.50%
The most profitable trade made by James Ede-Golightly
James Ede-Golightly's Trading History
Silence Therapeutics
Oct 12, 2020
―
Informative Buy
12.26K
£16.05K
Plant Health Care
Aug 23, 2016
Director
Informative Buy
20.00K
£56.29K
List of latest transactions for each holding click on a transaction to see James Ede-Golightly's performance on stock
You May Also Like
James Ede-Golightly insider profile FAQ
What is the percentage of profitable transactions made by James Ede-Golightly?
The percentage of profitable transactions made by James Ede-Golightly is 100%.
What is the average return per transaction made by James Ede-Golightly?
The average return per transaction made by James Ede-Golightly is 34.40%.
What stocks does James Ede-Golightly hold?
James Ede-Golightly holds: GB:SLN, GB:PHC stocks.
What was James Ede-Golightly’s latest transaction?
James Ede-Golightly latest transaction was an Informative Buy of 12.26K.
What was James Ede-Golightly's most profitable transaction?
James Ede-Golightly’s most profitable transaction was an Informative Buy of GB:SLN stock on October 12, 2020. The return on the trade was 43.50%.
What is James Ede-Golightly's role in Silence Therapeutics?
James Ede-Golightly's role in Silence Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.